SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123703
Filing Date
2022-04-27
Accepted
2022-04-27 16:30:53
Documents
3
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d352067ddef14a.htm DEF 14A 552991
2 GRAPHIC g352067g0001.jpg GRAPHIC 162423
3 GRAPHIC g352067g0002.jpg GRAPHIC 115338
  Complete submission text file 0001193125-22-123703.txt   936640
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33038 | Film No.: 22860123
SIC: 2834 Pharmaceutical Preparations